541 related articles for article (PubMed ID: 11555828)
1. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
Badawi AF; Cavalieri EL; Rogan EG
Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
3. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
Yamazaki H; Shimada T
Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
[TBL] [Abstract][Full Text] [Related]
4. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
Yamazaki H; Shaw PM; Guengerich FP; Shimada T
Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.
Lee AJ; Cai MX; Thomas PE; Conney AH; Zhu BT
Endocrinology; 2003 Aug; 144(8):3382-98. PubMed ID: 12865317
[TBL] [Abstract][Full Text] [Related]
6. Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
Shimada T; Watanabe J; Kawajiri K; Sutter TR; Guengerich FP; Gillam EM; Inoue K
Carcinogenesis; 1999 Aug; 20(8):1607-13. PubMed ID: 10426814
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytochrome P450 isoforms involved in 1-hydroxylation of pyrene.
Kim YD; Todoroki H; Oyama T; Isse T; Matsumoto A; Yamaguchi T; Kim H; Uchiyama I; Kawamoto T
Environ Res; 2004 Mar; 94(3):262-6. PubMed ID: 15016593
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5.
Lee AJ; Kosh JW; Conney AH; Zhu BT
J Pharmacol Exp Ther; 2001 Aug; 298(2):420-32. PubMed ID: 11454902
[TBL] [Abstract][Full Text] [Related]
11. Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17beta-estradiol in female Sprague-Dawley rats.
Badawi AF; Cavalieri EL; Rogan EG
Carcinogenesis; 2000 Aug; 21(8):1593-9. PubMed ID: 10910964
[TBL] [Abstract][Full Text] [Related]
12. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
Yamazaki H; Shimada T
Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1.
Crofts FG; Sutter TR; Strickland PT
Carcinogenesis; 1998 Nov; 19(11):1969-73. PubMed ID: 9855011
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
17. Prosubstrates of CYP3A4, the major human hepatic cytochrome P450: transformation into substrates by other P450 isoforms.
Stresser DM; Kupfer D
Biochem Pharmacol; 1998 Jun; 55(11):1861-71. PubMed ID: 9714305
[TBL] [Abstract][Full Text] [Related]
18. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
[TBL] [Abstract][Full Text] [Related]
19. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
[TBL] [Abstract][Full Text] [Related]
20. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.
Taguchi K; Konishi T; Nishikawa H; Kitamura S
Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]